The effect of bacterial toxins on platelet function

Toxins and Hemostasis: From Bench to Bedside

Volumn , Issue , 2011, Pages 637-651

  Kerrigan, Steven ^a   Cox, Dermot ^a  

^a ROYAL COLLEGE OF SURGEONS IN IRELAND   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 79958072759     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-90-481-9295-3_36     Document Type: Chapter

References (121)

1. Anderson, R., Steel, H.C., Cockeran, R., von Gottberg, A., de Gouveia, L., Klugman, K.P., Mitchell, T.J., Feldman, C., 2007. Comparison of the effects of macrolides, amoxicillin, ceftriaxone, doxycycline, tobramycin and fluoroquinolones, on the production of pneumolysin by Streptococcus pneumoniae in vitro. J. Antimicrob. Chemother. 60, 1155-1158.
2. Andonegui, G., Kerfoot, S.M., McNagny, K., Ebbert, K.V.J., Patel, K.D., Kubes, P., 2005. Platelets express functional Toll-like receptor-4. Blood 106, 2417-2423.
3. Arvand, M., Bhakdi, S., Dahlback, B., Preissner, K.T., 1990. Staphylococcus aureus alpha-toxin attack on human platelets promotes assembly of the prothrombinase complex. J. Biol. Chem. 265, 14377-14381.
4. Ashbaugh, C.D., Alberti, S., Wessels, M.R., 1998. Molecular analysis of the capsule gene region of group A Streptococcus: The has AB genes are sufficient for capsule expression. J. Bacteriol. 180, 4955-4959.
5. Aslam, R., Speck, E.R., Kim, M., Crow, A.R., Bang, K.W.A., Nestel, F.P., Ni, H., Lazarus, A.H., Freedman, J., Semple, J.W., 2006. Platelet Toll-like receptor expression modulates lipopolysaccharide-induced thrombocytopenia and tumor necrosis factor-α production in vivo. Blood 107, 637-641.
6. Baliakina, E.V., Gerasimovskaia, E.V., Romanov, Iu.A., Atakhanov, Sh.E., 1999. Role of Staphylococcus aureus hemolytic toxin-alpha in pathogenesis of infectious endocarditis: studies in vitro. Ter. Arkh. 71, 28-31.
7. Bayer, A.S., Ramos, M.D., Menzies, B.E., Yeaman, M.R., Shen, A.J., Cheung, A.L., 1997. Hyperproduction of alpha-toxin by Staphylococcus aureus results in paradoxically reduced virulence in experimental endocarditis: A host defense role for platelet microbicidal proteins. Infect. Immun. 65, 4652-4660.
8. Benton, K.A., Paton, J.C., Briles, D.E., 1997. Differences in virulence for mice among Streptococcus pneumoniae strains of capsular types 2, 3, 4, 5, and 6 are not attributable to differences in pneumolysin production. Infect. Immun. 65, 1237-1244.
9. Berg, M., Offermanns, S., Seifert, R., Schultz, G., 1994. Synthetic lipopeptide Pam3CysSer(Lys)4 is an effective activator of human platelets. Am. J. Physiol. Cell Physiol. 266, C1684-C1691.
10. Bernheimer, A.W., 1965. Staphylococcal alpha toxin. Ann. N.Y. Acad. Sci. 128, 112-123.
11. Bernheimer, A.W., Schwartz, L.L., 1965. Effect of staphylococcal and other bacterial toxins on platelets in vitro. J. Pathol. Bacteriol. 89, 209-223.
12. Berry, A.M., Paton, J.C., Hansman, D., 1992. Effect of insertional inactivation of the genes encoding pneumolysin and autolysin on the virulence of Streptococcus pneumoniae type 3. Microb. Pathog. 12, 87-93.
13. Berry, A.M., Yother, J., Briles, D.E., Hansman, D., Paton, J.C., 1989. Reduced virulence of a defined pneumolysin-negative mutant of Streptococcus pneumoniae. Infect. Immun. 57, 2037-2042.
14. Beutler, B., Hoebe, K., Du, X., Ulevitch, R.J., 2003. How we detect microbes and respond to them: The Toll-like receptors and their transducers. J. Leukoc. Biol. 74, 479-485.
15. Bhakdi, S., Bayley, H., Valeva, A., Walev, I., Walker, B., Kehoe, M., Palmer, M., 1996. Staphylococcal alpha-toxin, streptolysin-O, and Escherichia coli hemolysin: prototypes of pore-forming bacterial cytolysins. Arch. Microbiol. 165, 73-79.
16. Bhakdi, S., Tranum-Jensen, J., Sziegoleit, A., 1985. Mechanism of membrane damage by streptolysin-O. Infect. Immun. 47, 52-60.
17. Bisno, A.L., Stevens, D.L., 1996. Streptococcal infections of skin and soft tissues. N. Engl. J.Med. 334, 240-245.
18. Bryant, A.E., Bayer, C.R., Chen, R.Y., Guth, P.H., Wallace, R.J., Stevens, D.L., 2005. Vascular dysfunction and ischemic destruction of tissue in Streptococcus pyogenes infection: The role of streptolysin O-induced platelet/neutrophil complexes. J. Infect. Dis. 192, 1014-1022.
19. Carapetis, J.R., Steer, A.C., Mulholland, E.K., Weber, M., 2005. The global burden of group A streptococcal diseases. Lancet Infect. Dis. 5, 685-694.
20. Charpentier, E., Tuomanen, E., 2000. Mechanisms of antibiotic resistance and tolerance in Streptococcus pneumoniae. Microbes Infect. 2, 1855-1864.
21. Clark, S.R., Ma, A.C., Tavener, S.A., McDonald, B., Goodarzi, Z., Kelly, M.M., Patel, K.D., Chakrabarti, S., McAvoy, E., Sinclair, G.D., Keys, E.M., Allen-Vercoe, E., Devinney, R., Doig, C.J., Green, F.H., Kubes, P., 2007. Platelet TLR4 activates neutrophil extracellular traps to ensnare bacteria in septic blood. Nat. Med. 13, 463-469.
22. Cockeran, R., Durandt, C., Feldman, C., Mitchell, T.J., Anderson, R., 2002. Pneumolysin activates the synthesis and release of interleukin-8 by human neutrophils in vitro. J. Infect. Dis. 186, 562-565.
23. Cockerill, F.R., Hughes, J.G., Vetter, E.A., Mueller, R.A., Weaver, A.L., Ilstrup, D.M., Rosenblatt, J.E., Wilson, W.R., 1997. Analysis of 281, 797 consecutive blood cultures performed over an eight-year period: Trends in microorganisms isolated and the value of anaerobic culture of blood. Clin. Infect. Dis. 24, 403-418.
24. Cognasse, F., Hamzeh, H., Chavarin, P., Acquart, S., Genin, C., Garraud, O., 2005. Evidence of Toll-like receptor molecules on human platelets. Immunol. Cell Biol. 83, 196-198.
25. Cooling, L.L.W., Walker, K.E., Gille, T., Koerner, T.A.W., 1998. Shiga toxin binds human platelets via globotriaosylceramide (Pk Antigen) and a novel platelet glycosphingolipid. Infect. Immun. 66, 4355-4366.
26. Corey, G.R., 2009. Staphylococcus aureus bloodstream infections: definitions and treatment. Clin. Infect. Dis. 48(Suppl 4), S254-S259.
27. Csako, G., Suba, E., Elin, R., 1988. Endotoxin-induced platelet activation in human whole blood in vitro. Thromb. Haemost. 59, 378-382.
28. Curtis, M.A., Aduse-Opoku, J., Rangarajan, M., 2001. Cysteine Proteases of Porphyromonas gingivalis. Crit. Rev. Oral Biol. Med. 12, 192-216.
29. David, E.H., Jeremy, A.Y., Chris, W., 1998. Molecular basis for structural diversity in the core regions of the lipopolysaccharides of Escherichia coli and Salmonella enterica. Mol. Micro. 30, 221-232.
30. Davis, J.P., Chesney, P.J., Wand, P.J., LaVenture, M., 1980. Toxic-shock syndrome: epidemiologic features, recurrence, risk factors, and prevention. N. Engl. J. Med. 303, 1429-1435.
31. de Haas, C., Weeterings, C., Vughs, M., de Groot, P.G., van Strijp, J., Lisman, T., 2009. Staphylococcal superantigen-like 5 activates platelets and supports platelet adhesion under flow conditions, which involves glycoprotein Ibα and αIIbβ3. J. Thromb. Haemostas. 7, 1867-1874.
32. Dessing, M.C., Hirst, R.A., de Vos, A.F., van der Poll, T., 2009. Role of Toll-like receptors 2 and 4 in pulmonary inflammation and injury induced by pneumolysin in mice. PLoS One 4, e7993.
33. Fabrice, C., Hind, H.-C., Sandrine, L., Olivier, D., Bruno, P., Archie, M., Olivier, G., 2008. Tolllike receptor 4 ligand can differentially modulate the release of cytokines by human platelets. Br. J. Haematol. 141, 84-91.
34. Fitzgerald, J.R., Foster, T.J., Cox, D., 2006. The interaction of bacterial pathogens with platelets. Nat. Rev. Microbiol. 4, 445-457.
35. Fitzpatrick, R.E., Wijeyewickrema, L.C., Pike, R.N., 2009. The gingipains: scissors and glue of the periodontal pathogen, Porphyromonas gingivalis. Future Microbiol. 4, 471-487.
36. Fraser, J., Proft, T., 2008. The bacterial superantigen and superantigen-like proteins. Immunol. Rev. 225, 226-243.
37. García, A., Marini, R.P., Catalfamo, J.L., Knox, K.A., Schauer, D.B., Rogers, A.B., Fox, J.G., 2008. Intravenous Shiga toxin 2 promotes enteritis and renal injury characterized by polymorphonuclear leukocyte infiltration and thrombosis in Dutch Belted rabbits. Microbes Infect. 10, 650-656.
38. Gareau, R., Gruda, J., Micusan, V., 1989. Effect of toxic shock syndrome toxin-1 on human hemostatic parameters. Thromb. Res. 54, 349-356.
39. Ghosh, S., Polanowska-Grabowska, R., Fujii, J., Obrig, T., Gear, A., 2004. Shiga toxin binds to activated platelets. J. Thromb. Haemost. 2, 499-506.
40. Gilbert, R.J., Rossjohn, J., Parker, M.W., Tweten, R.K., Morgan, P.J., Mitchell, T.J., Errington, N., Rowe, A.J., Andrew, P.W., Byron, O., 1998. Self-interaction of pneumolysin, the pore-forming protein toxin of Streptococcus pneumoniae. J. Mol. Biol. 284, 1223-1237.
41. Guessous, F., Marcinkiewicz, M., Polanowska-Grabowska, R., Keepers, T., Obrig, T., Gear, A., 2005a. Shiga toxin 2 and lipopolysaccharide cause monocytic THP-1 cells to release factors which activate platelet function. Thromb. Haemost. 94, 1019-1027.
42. Guessous, F., Marcinkiewicz, M., Polanowska-Grabowska, R., Kongkhum, S., Heatherly, D., Obrig, T., Gear, A.R.L., 2005b. Shiga Toxin 2 and lipopolysaccharide induce human microvascular endothelial cells to release chemokines and factors that stimulate platelet function. Infect. Immun. 73, 8306-8316.
43. Guo, Y.-L., Liu, D.-Q., Bian, Z., Zhang, C.-Y., Zen, K., 2009. Down-Regulation of platelet surface CD47 expression in Escherichia coli O157:H7 infection-induced thrombocytopenia. PLoS ONE 4, e7131.
44. Hashimoto, K., Jayachandran, M., Owen, W., Miller, V., 2009. Aggregation and microparticle production through Toll-like receptor 4 activation in platelets from recently menopausal women. J. Cardiovasc. Pharmacol. 54, 57-62.
45. Hildebrand, A., Pohl, M., Bhakdi, S., 1991. Staphylococcus aureus alpha-toxin. Dual mechanism of binding to target cells. J. Biol. Chem. 266, 17195-17200.
46. Houldsworth, S., Andrew, P.W., Mitchell, T.J., 1994. Pneumolysin stimulates production of tumor necrosis factor alpha and interleukin-1 beta by human mononuclear phagocytes. Infect. Immun. 62, 1501-1503.
47. Hu, H., Peter, K., 2009. Staphylococcal superantigen-like 5 induces platelet activation and thrombosis via binding to GPIbα and GPVI. Circulation 120, S1080.
48. Ikigai, H., Nakae, T., 1985. Conformational alteration in alpha-toxin from Staphylococcus aureus concomitant with the transformation of the water-soluble monomer to the membrane oligomer. Biochem. Biophys. Res. Commun. 130, 175-181.
49. Ivanov, I.B., Gritsenko, V.A., Kuzmin, M.D., 2006. Staphylococcal secretory inhibitor of platelet microbicidal protein is associated with prostatitis source. J. Med. Microbiol. 55, 1645-1648.
50. Jayachandran, M., Brunn, G.J., Karnicki, K., Miller, R.S., Owen, W.G., Miller, V.M., 2007. In vivo effects of lipopolysaccharide and TLR4 on platelet production and activity: Implications for thrombotic risk. J. Appl. Physiol. 102, 429-433.
51. Johnson, M.K., Boese-Marrazzo, D., Pierce, W.A., 1981. Effects of pneumolysin on human polymorphonuclear leukocytes and platelets. Infect. Immun. 34, 171-176.
52. Johnson, M.K., Geoffroy, C., Alouf, J.E., 1980. Binding of cholesterol by sulfhydryl-activated cytolysins. Infect. Immun. 27, 97-101.
53. Kadioglu, A., Coward, W., Colston, M.J., Hewitt, C.R., Andrew, P.W., 2004. CD4-T-lymphocyte interactions with pneumolysin and pneumococci suggest a crucial protective role in the host response to pneumococcal infection. Infect. Immun. 72, 2689-2697.
54. Kanclerski, K., Mollby, R., 1987. Production and purification of Streptococcus pneumoniae hemolysin (pneumolysin). J. Clin. Microbiol. 25, 222-225.
55. Karpman, D., Papadopoulou, D., Nilsson, K., Sjogren, A.C., Mikaelsson, C., Lethagen, S., 2001. Platelet activation by Shiga toxin and circulatory factors as a pathogenetic mechanism in the hemolytic uremic syndrome. Blood 97, 3100-3108.
56. Kehoe, M.A., Miller, L., Walker, J.A., Boulnois, G.J., 1987. Nucleotide sequence of the streptolysin O (SLO) gene: structural homologies between SLO and other membrane-damaging, thiol-activated toxins. Infect. Immun. 55, 3228-3232.
57. Kuckleburg, C., McClenahan, D., Czuprynski, C., 2008a. Platelet activation by Histophilus somni and its lipooligosaccharide induces endothelial cell proinflammatory responses and platelet internalization. Shock 29, 189-196.
58. Kuckleburg, C., Tiwari, R., Czuprynski, C., 2008b. Endothelial cell apoptosis induced by bacteriaactivated platelets requires caspase-8 and -9 and generation of reactive oxygen species. Thromb. Haemost. 99, 363-372.
59. Kuckleburg, C.J., Sylte, M.J., Inzana, T.J., Corbeil, L.B., Darien, B.J., Czuprynski, C.J., 2005. Bovine platelets activated by Haemophilus somnus and its LOS induce apoptosis in bovine endothelial cells. Microb. Pathogen 38, 23-32.
60. Lappin, E., Ferguson, A.J., 2009. Gram-positive toxic shock syndromes. Lancet Infect. Dis. 9, 281-290.
61. Ler, S.G., Lee, F.K., Gopalakrishnakone, P., 2006. Trends in detection of warfare agents: detection methods for ricin, staphylococcal enterotoxin B and T-2 toxin. J. Chromatog. A. 1133, 1-12.
62. Lew, D.P., Waldvogel, F.A., 2004. Osteomyelitis. Lancet 364, 369-379.
63. Lindberg, A.A., Brown, J.E., Stramberg, N., Westling-Ryd, M., Schultz, J.E., Karlsson, K.A., 1987. Identification of the carbohydrate receptor for Shiga toxin produced by Shigella dysenteriae type 1. J. Biol. Chem. 262, 1779-1785.
64. Ling, H., Boodhoo, A., Hazes, B., Cummings, M.D., Armstrong, G.D., Brunton, J.L., Read, R.J., 1998. Structure of the Shiga-like toxin I B-pentamer complexed with an analogue of its receptor Gb3. Biochemistry 37, 1777-1788.
65. Lopez, R., Garcia, E., Garcia, P., Garcia, J.L., 1997. The pneumococcal cell wall degrading enzymes: A modular design to create new lysins? Microb. Drug Resist. 3, 199-211.
66. Lourbakos, A., Potempa, J., Travis, J., D'Andrea, M.R., Andrade-Gordon, P., Santulli, R., Mackie, E.J., Pike, R.N., 2001a. Arginine-specific protease from Porphyromonas gingivalis activates protease-activated receptors on human oral epithelial cells and induces interleukin-6 secretion. Infect. Immun. 69, 5121-5130.
67. Lourbakos, A., Yuan, Y., Jenkins, A.L., Travis, J., Andrade-Gordon, P., Santulli, R., Potempa, J., Pike, R.N., 2001b. Activation of protease-activated receptors by gingipains from Porphyromonas gingivalis leads to platelet aggregation: A new trait in microbial pathogenicity. Blood 97, 3790-3797.
68. Lowy, F.D., 1998. Staphylococcus aureus infections. N. Engl. J. Med. 339, 520-532.
69. Lynch, J.P., Zhanel, G.G., 2009. Streptococcus pneumoniae: epidemiology, risk factors, and strategies for prevention. Semin. Respir. Crit. Care Med. 30, 189-209.
70. Malley, R., Henneke, P., Morse, S.C., Cieslewicz, M.J., Lipsitch, M., Thompson, C.M., Kurt-Jones, E., Paton, J.C., Wessels, M.R., Golenbock, D.T., 2003. Recognition of pneumolysin by Tolllike receptor 4 confers resistance to pneumococcal infection. Proc. Natl. Acad. Sci. U.S.A. 100, 1966-1971.
71. Manohar, M., Maheswaran, S.K., Frommes, S.P., Lindorfer, R.K., 1967. Platelet damaging factor, a fifth activity of staphylococcal alpha-toxin. J. Bacteriol. 94, 224-231.
72. Mitchell, T.J., Andrew, P.W., Saunders, F.K., Smith, A.N., Boulnois, G.J., 1991. Complement activation and antibody binding by pneumolysin via a region of the toxin homologous to a human acute-phase protein. Mol. Microbiol. 5, 1883-1888.
73. Montrucchio, G., Bosco, O., Del Sorbo, L., Fascio Pecetto, P., Lupia, E., Goffi, A., Omede, P., Emanuelli, G., Camussi, G., 2003. Mechanisms of the priming effect of low doses of lipopolysaccharides on leukocyte-dependent platelet aggregation in whole blood. Thromb. Haemost. 90, 872-881.
74. Morath, S., von Aulock, S., Hartung, T., 2005. Structure/function relationships of lipoteichoic acids. J. Endotoxin. Res. 11, 348-356.
75. Moreillon, P., Que, Y.A., 2004. Infective endocarditis. Lancet 363, 139-149.
76. Morgan, P.J., Hyman, S.C., Byron, O., Andrew, P.W., Mitchell, T.J., Rowe, A.J., 1994. Modeling the bacterial protein toxin, pneumolysin, in its monomeric and oligomeric form. J. Biol. Chem. 269, 25315-25320.
77. Morganti, R., Marcondes, S., Baldasso, P., Marangoni, S., De Nucci, G., Antunes, E., 2008. Inhibitory effects of staphylococcal enterotoxin type B on human platelet adhesion in vitro. Platelets 19, 432-439.
78. Morigi, M., Galbusera, M., Binda, E., Imberti, B., Gastoldi, S., Remuzzi, A., Zoja, C., Remuzzi, G., 2001. Verotoxin-1-induced up-regulation of adhesive molecules renders microvascular endothelial cells thrombogenic at high shear stress. Blood 98, 1828-1835.
79. Mortara, L.A., Bayer, A.S., 1993. Staphylococcus aureus bacteremia and endocarditis. New diagnostic and therapeutic concepts. Infect. Dis. Clin. North Am. 7, 53-68.
80. Naito, M., Sakai, E., Shi, Y., Ideguchi, H., Shoji, M., Ohara, N., Yamamoto, K., Nakayama, K., 2006. Porphyromonas gingivalis-induced platelet aggregation in plasma depends on Hgp44 adhesin but not Rgp proteinase. Mol. Micro. 59, 152-167.
81. Nylander, M., Lindahl, T.L., Bengtsson, T., Grenegard, M., 2008. The periodontal pathogen Porphyromonas gingivalis sensitises human blood platelets to epinephrine. Platelets 19, 352-358.
82. O'Brien, K.L., Wolfson, L.J., Watt, J.P., Henkle, E., Deloria-Knoll, M., McCall, N., Lee, E., Mulholland, K., Levine, O.S., Cherian, T., 2009. Burden of disease caused by Streptococcus pneumoniae in children younger than 5 years: global estimates. Lancet 374, 893-902.
83. Obrig, T., Moran, T., Brown, J., 1987. The mode of action of Shiga toxin on peptide elongation of eukaryotic protein synthesis. Biochem. J. 244, 287-294.
84. Palermo, M.S., Exeni, R.A., Fernandez, G.C., 2009. Hemolytic uremic syndrome: pathogenesis and update of interventions. Expert. Rev. Anti-infective Therapy 7, 697-707.
85. Paton, J.C., Berry, A.M., Lock, R.A., Hansman, D., Manning, P.A., 1986. Cloning and expression in Escherichia coli of the Streptococcus pneumoniae gene encoding pneumolysin. Infect. Immun. 54, 50-55.
86. Paton, J.C., Ferrante, A., 1983. Inhibition of human polymorphonuclear leukocyte respiratory burst, bactericidal activity, and migration by pneumolysin. Infect. Immun. 41, 1212-1216.
87. Paton, J.C., Rowan-Kelly, B., Ferrante, A., 1984. Activation of human complement by the pneumococcal toxin pneumolysin. Infect. Immun. 43, 1085-1087.
88. Pham, K., Feik, D., Hammond, B.F., Rams, T.E., Whitaker, E.J., 2002. Aggregation of human platelets by gingipain-R from Porphyromonas gingivalis cells and membrane vesicles. Platelets 13, 21-30.
89. Rodgers, G.L., Arguedas, A., Cohen, R., Dagan, R., 2009. Global serotype distribution among Streptococcus pneumoniae isolates causing otitis media in children: potential implications for pneumococcal conjugate vaccines. Vaccine 27, 3802-3810.
90. Satoh, T., Yamashita, Y., Kamiyama, T., Watanabe, J., Steiner, B., Hadváry, P., Arisawa, M., 1993. Tetrafibricin: A nonpeptidic fibrinogen receptor inhibitor from Streptomyces neyagawaensis (I) its GPIIb/IIIa blockage on solid phase binding assay. Thromb. Res. 72, 389-400.
91. Schmitt, C., Meysick, K., O'Brien, A., 1999. Bacterial toxins: Friends or foes? Emerg. Infect. Dis. 5, 224-234.
92. Shah, R., 2009. Protease-activated receptors in cardiovascular health and diseases. Am. Heart J. 157, 253-262.
93. Shannon, O., Hertzen, E., Norrby-Teglund, A., Morgelin, M., Sjobring, U., Bjorck, L., 2007. Severe streptococcal infection is associated with M protein-induced platelet activation and thrombus formation. Mol. Microbiol. 65, 1147-1157.
94. Shashkin, P.N., Brown, G.T., Ghosh, A., Marathe, G.K., McIntyre, T.M., 2008. Lipopolysaccharide is a direct agonist for platelet RNA splicing. J Immunol 181, 3495-3502.
95. Sheu, J.R., Hsiao, G., Lee, C., Chang, W., Lee, L.W., Su, C.H., Lin, C.H., 2000a. Antiplatelet activity of Staphylococcus aureus lipoteichoic acid is mediated through a cyclic AMP pathway. Thromb. Res. 99, 249-258.
96. Sheu, J.R., Lee, C.R., Lin, C.H., Hsiao, G., Ko, W.C., Chen, Y.C., Yen, M.H., 2000b. Mechanisms involved in the antiplatelet activity of Staphylococcus aureus lipoteichoic acid in human platelets. Thromb. Haemost. 83, 777-784.
97. Shibazaki, M., Kawabata, Y., Yokochi, T., Nishida, A., Takada, H., Endo, Y., 1999. Complementdependent accumulation and degradation of platelets in the lung and liver induced by injection of lipopolysaccharides. Infect. Immun. 67, 5186-5191.
98. Shiraki, R., Inoue, N., Kawasaki, S., Takei, A., Kadotani, M., Ohnishi, Y., Ejiri, J., Kobayashi, S., Hirata, K., Kawashima, S., Yokoyama, M., 2004. Expression of Toll-like receptors on human platelets. Thromb. Res. 113, 379-385.
99. Shoma, S., Tsuchiya, K., Kawamura, I., Nomura, T., Hara, H., Uchiyama, R., Daim, S., Mitsuyama, M., 2008. Critical involvement of pneumolysin in production of interleukin-1α and caspase-1- dependent cytokines in infection with Streptococcus pneumoniae in vitro: A novel function of pneumolysin in caspase-1 activation. Infect. Immun. 76, 1547-1557.
100. Siegel, I., Cohen, S., 1964. Action of staphylococcal toxin on human platelets. J. Infect. Dis. 114, 488-502.
101. Spreer, A., Kerstan, H., Bottcher, T., Gerber, J., Siemer, A., Zysk, G., Mitchell, T.J., Eiffert, H., Nau, R., 2003. Reduced release of pneumolysin by Streptococcus pneumoniae in vitro and in vivo after treatment with nonbacteriolytic antibiotics in comparison to ceftriaxone. Antimicrob. Agents Chemother. 47, 2649-2654.
102. Stahl, A., Sartz, L., Nelsson, A., Bekassy, Z., Karpman, D., 2009. Shiga toxin and lipopolysaccharide induce platelet-leukocyte aggregates and tissue factor release, a thrombotic mechanism in hemolytic uremic syndrome. PLoS One 4, e6990.
103. Stahl, A.-l., Svensson, M., Morgelin, M., Svanborg, C., Tarr, P.I., Mooney, J.C., Watkins, S.L., Johnson, R., Karpman, D., 2006. Lipopolysaccharide from enterohemorrhagic Escherichia coli binds to platelets through TLR4 and CD62 and is detected on circulating platelets in patients with hemolytic uremic syndrome. Blood 108, 167-176.
104. Stevens, D.L., Tanner, M.H., Winship, J., Swarts, R., Ries, K.M., Schlievert, P.M., Kaplan, E., 1989. Severe group A streptococcal infections associated with a toxic shock-like syndrome and scarlet fever toxin A. N. Engl. J. Med. 321, 1-7.
105. Stockbauer, K.E., Magoun, L., Liu, M., Burns, E.H., Gubba, S., Renish, S., Pan, X., Bodary, S.C., Baker, E., Coburn, J., Leong, J.M., Musser, J.M., 1999. A natural variant of the cysteine protease virulence factor of group A Streptococcus with an arginine-glycine-aspartic acid (RGD) motif preferentially binds human integrins αVβ3 and αIIbβ3. Proc. Natl. Acad. Sci. U.S.A. 96, 242-247.
106. Taylor, F.B. Jr., Bryant, A.E., Blick, K.E., Hack, E., Jansen, P.M., Kosanke, S.D., Stevens, D.L., 1999. Staging of the baboon response to group A streptococci administered intramuscularly: A descriptive study of the clinical symptoms and clinical chemical response patterns. Clin. Infect. Dis. 29, 167-177.
107. te Loo, D., H., L.A., van der Velden, T., Vermeer, M., Preyers, F., Demacker, P., van den Heuvel, L., van Hinsbergh, V., 2000. Binding and transfer of verocytotoxin by polymorphonuclear leukocytes in hemolytic uremic syndrome. Blood 95, 3396-3402.
108. Thorpe, C.M., Flaumenhaft, R., Hurley, B., Jacewicz, M., Acheson, D.W.K., Keusch, G.T., 1999. Shiga toxins do not directly stimulate alpha-granule secretion or enhance aggregation of human platelets. Acta Haematologica 102, 51-55.
109. Tilley, S.J., Orlova, E.V., Gilbert, R.J., Andrew, P.W., Saibil, H.R., 2005. Structural basis of pore formation by the bacterial toxin pneumolysin. Cell 121, 247-256.
110. Tran, U., Boyle, T., Shupp, J., Hammamieh, R., Jett, M., 2006. Staphylococcal enterotoxin B initiates protein kinase C translocation and eicosanoid metabolism while inhibiting thrombininduced aggregation in human platelets. Mol. Cell. Biochem. 288, 171-178.
111. Valeva, A., Weisser, A., Walker, B., Kehoe, M., Bayley, H., Bhakdi, S., Palmer, M., 1996. Molecular architecture of a toxin pore: A 15-residue sequence lines the transmembrane channel of staphylococcal alpha-toxin. EMBO J. 15, 1857-1864.
112. van der Poll, T., Opal, S.M., 2009. Pathogenesis, treatment, and prevention of pneumococcal pneumonia. Lancet 374, 1543-1556.
113. Walker, J.A., Allen, R.L., Falmagne, P., Johnson, M.K., Boulnois, G.J., 1987. Molecular cloning, characterization, and complete nucleotide sequence of the gene for pneumolysin, the sulfhydryl-activated toxin of Streptococcus pneumoniae. Infect. Immun. 55, 1184-1189.
114. Ward, J.R., Bingle, L., Judge, H.M., Brown, S.B., Storey, R.F., Whyte, M.K., Dower, S.K., Buttle, D.J., Sabroe, I., 2005. Agonists of toll-like receptor (TLR)2 and TLR4 are unable to modulate platelet activation by adenosine diphosphate and platelet activating factor. Thromb. Haemost. 94, 831-838.
115. White, J., Rao, G., Gerrard, J., 1974. Effects of the ionophore A23187 on blood platelets I. Influence on aggregation and secretion. Am. J. Pathol. 77, 135-149.
116. Whitworth, N., Barradas, M., Mikhailidis, D., Dandona, P., 1989. An investigation into the effects of bacterial lipopolysaccharide on human platelets. Eur. J. Haematol. 43, 112-119.
117. Wilson, M., Blum, R., Dandona, P., Mousa, S., 2001. Effects in humans of intravenously administered endotoxin on soluble cell-adhesion molecule and inflammatory markers: A model of human diseases. Clin. Exper. Pharmacol. Physiol. 28, 376-380.
118. Yagi, H., Narita, N., Matsumoto, M., Sakurai, Y., Ikari, H., Yoshioka, A., Kita, E., Ikeda, Y., Titani, K., Fujimura, Y., 2001. Enhanced low shear stress induced platelet aggregation by Shiga-like toxin 1 purified from Escherichia coli O157. Am. J. Hematol. 66, 105-115.
119. Yeaman, M., Bayer, A., 2006. Antimicrobial peptides versus invasive infections. Curr. Top. Microbiol. Immunol. 306, 111-152.
120. Yeaman, M.R., Bayer, A.S., Koo, S.P., Foss, W., Sullam, P.M., 1998. Platelet microbicidal proteins and neutrophil defensin disrupt the Staphylococcus aureus cytoplasmic membrane by distinct mechanisms of action. J. Clin. Invest. 101, 178-187.
121. Zähringer, U., Lindner, B., Inamura, S., Heine, H., Alexander, C., 2008. TLR2 - promiscuous or specific? A critical re-evaluation of a receptor expressing apparent broad specificity. Immunobiology 213, 205-224.